Premium
Benralizumab strongly reduces blood basophils in severe eosinophilic asthma
Author(s) -
Lommatzsch Marek,
Marchewski Hannes,
Schwefel Georg,
Stoll Paul,
Virchow Johann Christian,
Bratke Kai
Publication year - 2020
Publication title -
clinical and experimental allergy
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 1.462
H-Index - 154
eISSN - 1365-2222
pISSN - 0954-7894
DOI - 10.1111/cea.13720
Subject(s) - benralizumab , asthma , immunology , eosinophilic , medicine , eosinophil , mepolizumab , pathology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom